Latest From Our Blog
What we offer
Custom Research Platforms: Flexible AI-driven frameworks for discovery, data analysis, and innovation across healthcare, engineering, space, and energy.
Data Solutions: Generation and analysis of synthetic datasets for complex medical and environmental challenges.
Scalable Innovation Models: Implementation of frameworks like Focused Research Organizations (FROs) for targeted, efficient R&D.
End-to-End Project Management: From ideation to execution, ensuring measurable impact and market readiness.
Real Results, Measurable Impact
30% faster development timelines
Reduced costs with advanced AI and global expertise
Accelerated market entry for innovative solutions
How we drive impact
With our partners, we are accelerating the growth of solutions in fields as health and healthcare. Together, we are committed to making a positive impact in the world by improving health outcomes and creating a better future for individuals and communities.
About Chelonia
Chelonia bridges the gap between groundbreaking ideas and impactful solutions by serving two distinct audiences: innovation-driven industries and academic spin-offs.
For industries, we provide tailored research platforms and advanced AI-driven tools to accelerate innovation, optimize costs, and bring scalable solutions to market faster. Whether in healthcare, engineering, space, or energy, our expertise transforms complex challenges into growth opportunities.
For academic spin-offs, we offer the strategic support needed to turn cutting-edge research into successful ventures. From building custom frameworks to navigating market entry, Chelonia empowers researchers to translate their ideas into real-world impact.
The complexity of today’s projects often requires the orchestration of a multistakeholder approach, aligning diverse expertise and resources. This frequently leads us to explore participation or even initiate concepts naturally aligned with European funding frameworks like Horizon Europe, further amplifying the reach and impact of our work.
By leveraging a global network of T-shaped professionals and state-of-the-art technologies, Chelonia delivers tailored solutions that reduce development time, drive sustainable growth, and create measurable value for both industries and academia.
Silvano Coletti - Founder & CEO, Chelonia SA
Silvano holds a BA and MSc in Engineering with advanced training from MIT and Harvard. A former student of Nobel laureate Ilya Prigogine, he founded one of Europe’s largest biomass power plants, and pioneered a €100M marketplace for industrial by-products. Active in the pharmaceutical industry since 2009, he authored "Exscalate4CoV: High-Performance Computing for COVID Drug Discovery", featuring contributions from Nobel laureate Arieh Warshel and Deputy Director General DGCONNECT Thomas Skordas.
Silvano also served pro bono as a United Nations delegate for a major African humanitarian organization.
DrugReKindle
Chelonia incubates breakthrough projects like DrugReKindle, a Swiss initiative revolutionizing drug repurposing and design. Powered by a clinically validated AI platform, DrugReKindle accelerates drug candidates to IND-ready trials, offering end-to-end services from in silico screening to biological validation—all in one streamlined process.